14 reports

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Biosimilar
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • EyeGate Pharmaceuticals, Inc.

Gerald Cagle said: " I am delighted to join Eyevensys' Board and look forward to working with a strong team and unlock the potential of its pioneering ocular drug delivery technology.

  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Product Initiative

Gerald Cagle said: " I am delighted to join Eyevensys' Board and look forward to working with a strong team and unlock the potential of its pioneering ocular drug delivery technology.

  • Immunotherapy
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Promethera Biosciences S.A.

The company provides services such as drug formulations, drug delivery, drug discovery, clinical trials, ocular therapeutics, eye treatment services.

  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Galapagos NV
  • RETINAL VEIN OCCLUSION - PIPELINE BY GRAYBUG VISION INC, H1 2018

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Medical Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • United States

It is important to choose the drug and route of delivery to ensure penetration to the site of the ocular inflammation.

  • Monoclonal Antibody
  • Forecast
  • Market Size
  • Allergan plc
  • Clearside Biomedical, Inc.
  • DIABETIC MACULAR EDEMA - PIPELINE BY FORMYCON AG, H1 2019

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Company
  • Product Initiative
  • DIABETIC MACULAR EDEMA - PIPELINE BY GRAYBUG VISION INC, H2 2019

Graybug Vision' s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye.

  • Medical Biotechnology
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Clearside Biomedical, Inc.

Graybug Vision" s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye.

  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Pharmaceutical
  • Allergan plc

EGP-## will be administered using the EyeGate II Ocular Drug Delivery System.

  • Autoimmune Disease
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Galapagos NV

Ocular Immunology and Inflammatory; ##: ##-##.

  • Monoclonal Antibody
  • AbbVie Inc.
  • Clearside Biomedical, Inc.
  • pSivida Corp.
  • Santen Pharmaceutical Co., Ltd.

The company offers its products through its proprietary FluidCrystal drug delivery technologies such as injection depot, topical bioadhesive delivery, and nanoparticle delivery technologies.

  • Chemotherapy
  • Monoclonal Antibody
  • Neurological Disorder
  • Pharmaceutical
  • Product Initiative

Graybug Vision' s proprietary ocular drug delivery technologies enable the delivery of the compounds to the various compartments of the eye.

  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Research And Development
  • Regeneron Pharmaceuticals, Inc.

The technology has proved to be compatible with subcutaneous, intra-articular and intra-ocular drug delivery.

  • Monoclonal Antibody
  • United States
  • Alnylam Pharmaceuticals, Inc.
  • Biologics, Inc.
  • Halozyme Therapeutics, Inc.